IND Application for a Phase Ⅲ Clinical Study of KN026 Combined with Albumin-bound Docetaxel as Neoadjuvant Treatment for Breast Cancer was Approved
SUZHOU,China,Oct. 17,2024-- Alphamab Oncology (stock code: 9966 HK) and CSPC Pharmaceutical Group Co.,Ltd.("CSPC")(stock code: 1093.HK) jointly announced that an application for a phase III